SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- Molecular
Data Inc. (Nasdaq: MKD), a leading technology-driven platform in
China's chemical industry, today
announced that it has reached a strategic partnership memorandum
for a potential transaction, including a stake in a renowned
Chinese logistics player with close to a decade of domain
In 2020, the chemical logistics business surpassed the
USD50 billion mark and there are
approximately 300,000 trucks being deployed in hazardous materials
The collaboration will deploy systems to accurately dispatch
these trucks and such a strengthened logistics capability will
address inadequacies in the transactions, as customers will be able
to increase logistics efficiency and reduce costs.
About Molecular Data Inc.
Molecular Data Inc. is a leading technology-driven platform in
China's chemical industry,
connecting participants along the chemical value chain through
integrated solutions. The Company delivers e-commerce solutions,
financial solutions, warehousing and logistics solutions, and SaaS
suite that are intended to solve pain points for participants in
the traditional chemical industry. Built upon a comprehensive
knowledge engine and artificial intelligence (AI) capabilities, the
Company's e-commerce solutions are mainly offered through its
online platform, consisting of molbase.com,
molbase.cn, Moku Data WeChat account, Chemical Community APP
and other ancillary platforms.
Safe Harbor Statement
This announcement contains forward-looking statements. These
statements are made under the "safe harbor" provisions of the U.S.
Private Securities Litigation Reform Act of 1995. These
forward-looking statements can be identified by terminology such as
"will," "expects," "anticipates," "aims," "future," "intends,"
"plans," "believes," "estimates," "confident," "potential,"
"continue" or other similar expressions. Among other things, the
quotations from management in this announcement, as well as the
Company's strategic and operational plans, contain forward-looking
statements. The Company may also make written or oral
forward-looking statements in its periodic reports to the U.S.
Securities and Exchange Commission, in its annual report to
shareholders, in press releases and other written materials and in
oral statements made by its officers, directors or employees to
third parties. Statements that are not historical facts, including
but not limited to statements about the Company's beliefs and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties, and a variety
of factors could cause actual results to differ materially from
those contained in any forward-looking statement, including but not
limited to the following: the Company's goals and strategies; the
Company's future business development, results of operations and
financial condition; the expected growth of the chemical market;
the Company's ability to monetize the user base; fluctuations in
general economic and business conditions in China; the potential impact of the COVID-19 to
the Company's business operations and the economy in China and elsewhere generally; and assumptions
underlying or related to any of the foregoing. Further information
regarding these and other risks is included in the Company's
filings with the Securities and Exchange Commission. All
information provided in this press release and in the attachments
is as of the date of the press release, and the Company undertakes
no duty to update such information, except as required under
SOURCE Molecular Data Inc.